by dmsAdmin | Jul 9, 2020
Precision radiopharmaceutical diagnostic imaging procedures help identify abnormalities early in the progress of a disease —before many medical problems are apparent with other diagnostic tests. Despite the proven effectiveness of radiopharmaceuticals, such as Axumin...
by dmsAdmin | Jun 18, 2020
Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use in PET imaging for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients...
by dmsAdmin | Jun 12, 2020
This post was written by John W. Mitchell and first appeared on DOTmed HealthCare Business Daily News. It has been reposted here with permission of the publisher. Two sources report that they are responding to rapidly changing demands of their hospital clients during...
by dmsAdmin | Jun 4, 2020
Prostate cancer is the second-leading cause of death among men in the United States. Imaging for the disease, especially when it comes to recurrences, has traditionally been challenging, but recent advances give hope for better outcomes. While prostate cancer is...
by dmsAdmin | May 12, 2020
Alzheimer’s disease is the sixth leading cause of death in the United States. Around one in three American seniors die from Alzheimer’s or another dementia, making it a bigger killer than breast and prostate cancer combined. In fact, deaths from Alzheimer’s disease...
